the claimed invention of the patent relates to the use of the compound known as carvedilol for the manufacture of a medicament for decreasing mortality resulting from congestive heart failure and to a method for decreasing such mortality comprising the administration of carvedilol.
the first reporting period expires at the end of the third calendar month following the first supply of carvedilol.
(h) not to seek a decrease in the price at which its carvedilol products are listed on the schedule of pharmaceutical benefits.